Journal of Thrombosis and Haemostasis, 1538-7933

Journal

More filtering options
  1. 2011
  2. A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).

    Gringeri, A., Björn Lundin, Mackensen, S. V., Mantovani, L. & Mannucci, P. M., 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 700-710

    Research output: Contribution to journalArticle

  3. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

    Andreas Hillarp, Baghaei, F., Blixter, I. F., Gustafsson, K. M., Stigendal, L., Sten-Linder, M., Strandberg, K. & Lindahl, T. L., 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 133-139

    Research output: Contribution to journalArticle

  4. Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.

    van Os, G. M. A., Meijers, J. C. M., Ağar, C., Valls Serón, M., Marquart, J. A., Per Åkesson, Urbanus, R. T., Derksen, R. H. W. M., Heiko Herwald, Mörgelin, M. & de Groot, P. G., 2011, In : Journal of Thrombosis and Haemostasis. 9, 12, p. 2447-2456

    Research output: Contribution to journalArticle

  5. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    Agersø, H., Brophy, D. F., Pelzer, H., Martin, E. J., Carr, M., Hedner, U. & Ezban, M., 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 333-338

    Research output: Contribution to journalArticle

  6. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).

    Tiede, A., Friedrich, U., Stenmo, C., Allen, G., Giangrande, P., Goudemand, J., Hay, C., Holmström, E. M., Klamroth, R., Lethagen, S., McKenzie, S., Miesbach, W., Negrier, C., Yuste, V. J. & Erik Berntorp, 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 1191-1199

    Research output: Contribution to journalArticle

  7. Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.

    Högberg, C., Olof Gidlöf, Tan, C., Svensson, S., Öhman, J., David Erlinge & Björn Olde, 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 361-372

    Research output: Contribution to journalArticle

  8. Wide temperature range testing with sonoclot plateletfunction and ROTEM EXTEM/FIBTEM/APTEM test

    Ulf Schött, Brokopp, J., Mårtensson, J., Attila Frigyesi & Hans Friberg, 2011, In : Journal of Thrombosis and Haemostasis. 9, s2, p. 91 1 p., P-MO-104.

    Research output: Contribution to journalPublished meeting abstract

  9. Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden

    R. Ljung & ANNIKA MÅRTENSSON, 2011 Jul 1, In : Journal of Thrombosis and Haemostasis. 9, p. 462 1 p., P-TU-492.

    Research output: Contribution to journalPublished meeting abstract

  10. 2012
  11. Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.

    Knoebl, P., Paese, M., Baudo, F., Collins, P., Huth-Kühne, A., Nemes, L., Pellegrini, F., Lilian Tengborn & Lévesque, H., 2012, In : Journal of Thrombosis and Haemostasis. 10, 4, p. 622-631

    Research output: Contribution to journalArticle

  12. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

    Clark, C. A., Vatsyayan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2383-2391

    Research output: Contribution to journalArticle

  13. Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?

    Hermans, C., Jan Astermark & De Moerloos, P., 2012, In : Journal of Thrombosis and Haemostasis. 10, 10, p. 2194-2196

    Research output: Contribution to journalLetter

  14. Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study.

    Kristinsson, S. Y., Goldin, L., Ingemar Turesson, Hultcrantz, M., Björkholm, M. & Landgren, O., 2012, In : Journal of Thrombosis and Haemostasis. 10, 5, p. 962-964

    Research output: Contribution to journalLetter

  15. Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.

    Gopalakrishnan, R., Pendurthi, U. R., Hedner, U., Agersø, H., Esmon, C. T. & Rao, L. V. M., 2012, In : Journal of Thrombosis and Haemostasis. 10, 5, p. 971-973

    Research output: Contribution to journalLetter

  16. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).

    Pabinger, I., Vossen, C. Y., Lang, J., Conard, J., García-Dabrio, M. C., Miesbach, W., Legnani, C., Peter Svensson, Kaider, A. & Rosendaal, F. R., 2012, In : Journal of Thrombosis and Haemostasis. 10, 2, p. 217-222

    Research output: Contribution to journalArticle

  17. Origin of Swedish hemophilia A mutations

    Halldén, C., Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2012, In : Journal of Thrombosis and Haemostasis. 10, 12, p. 2503-2511

    Research output: Contribution to journalArticle

  18. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    Collins, P. W., Møss, J., Knobe, K., Groth, A., Colberg, T. & Watson, E., 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2305-2312

    Research output: Contribution to journalArticle

  19. 2013
  20. 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics, and preliminary efficacy in hemophilia patients with inhibitors.

    Rolf Ljung, Karim, F. A., Saxena, K., Suzuki, T., Arkhammar, P., Rosholm, A. & Giangrande, P., 2013, In : Journal of Thrombosis and Haemostasis. 11, 7, p. 1260-1268

    Research output: Contribution to journalArticle

  21. Origin of Swedish hemophilia B mutations

    Hallden, C., Annika Mårtensson, Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2013, In : Journal of Thrombosis and Haemostasis. 11, 11, p. 2001-2008

    Research output: Contribution to journalArticle

  22. 2014
  23. Definitions in hemophilia: communication from the SSC of the ISTH

    Blanchette, V. S., Key, N. S., Rolf Ljung, Manco-Johnson, M. J., Van Den Berg, H. M. & Srivastava, A., 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1935-1939

    Research output: Contribution to journalArticle

  24. Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.

    Andreas Hillarp, Gustafsson, K. M., Faxälv, L., Strandberg, K., Baghaei, F., Fagerberg Blixter, I., Berndtsson, M. & Lindahl, T. L., 2014, In : Journal of Thrombosis and Haemostasis. 12, 9, p. 1545-1553

    Research output: Contribution to journalArticle

  25. Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma

    Hultcrantz, M., Pfeiffer, R. M., Bjorkholm, M., Goldin, L. R., Ingemar Turesson, Schulman, S., Landgren, O. & Kristinsson, S. Y., 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1816-1821

    Research output: Contribution to journalArticle

  26. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    Eckhardt, C. L., Jan Astermark, Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Peters, M., Fijnvandraat, K. & Kuijpers, T. W., 2014, In : Journal of Thrombosis and Haemostasis. 12, 8, p. 1294-1301

    Research output: Contribution to journalArticle